SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DYAX: Dyax Corp.
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
197 20 0 DYAX
Emcee:  SI (no user) Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
47Further CAT / DYAX deal, with the former in the driving seat. - Message 18405493nigel bates-1/6/2003
46Message 18284528 <i>New research on HTS Biosystems' and Applied Biosysnigel bates-11/29/2002
45BERKELEY, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 16, 2002--XOMA Ltnigel bates-10/16/2002
44Press Release Source: Dyax Corp. Dyax Presents Interim Results From its Phase keokalani'nui-9/25/2002
43Dyax: DX-88 Clinical Trial Interim Results Positive Wednesday September 25, 9:3keokalani'nui-9/25/2002
42CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 9, 2002--Dyax Corp. (Nasdaq: DYAX - Newnigel bates-9/10/2002
41CAMBRIDGE, Mass.--(BW HealthWire)--July 2, 2002--Dyax Corp. (Nasdaq: DYAX - Newsnigel bates-7/3/2002
40Dyax Announces Collaboration With AstraZeneca On Antibody Discovery and Optimizanigel bates-5/14/2002
39Dyax Corp. Announces First Quarter 2002 Financial Results CAMBRIDGE, Mass.--(BWnigel bates-4/25/2002
38CAMBRIDGE, Mass.--(BW HealthWire)--April 10, 2002--Dyax Corp. (Nasdaq: DYAX - nenigel bates-4/10/2002
37: J Clin Invest 2002 Mar 1;109(5):661-670 Related Articles, Books, LinkOut Ekeokalani'nui-3/13/2002
36this POS went from 12 to 4 in less than 3 months, is there any hope ??? Bottom farkarooski-3/12/2002
35Dyax and Amersham Biosciences Announce Agreement for Novel Affinity Ligands in Snigel bates-3/6/2002
34Any feedback on why the market was not happy with the conference call? Disclosuaknahow-2/14/2002
33Like the company, was surprised about the fx losses. Would have thought they coaknahow-2/14/2002
32Cheers, Mike. Some interesting stuff there - "...2:50 Yeast Display for Afnigel bates-2/13/2002
31Sorry, got back too late to delete. Alta has been holder of shares since at lesaknahow-2/12/2002
30This appears new to me, at least Alta does not appear to be listed as one of theaknahow-2/12/2002
29healthtech.comMike McFarland-2/12/2002
28More parking (but interested if anyone has heard anything on this collaboration)nigel bates-2/4/2002
27Just parking from the last 10K ...Our proprietary position in the field of phagnigel bates-2/4/2002
26CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 4, 2001--Dyax Corp. (Nasdaq: DYAX - newsnigel bates-12/4/2001
25Dyax Acquires Exclusive Rights Related to Angiogenesis Target CAMBRIDGE, Mass.-nigel bates-11/27/2001
24Cambridge Antibody Technology Announces Grant of Antibody Expression Library Patkeokalani'nui-9/19/2001
23Xoma CEO said this on web cast last Friday. "With the partnerships withaknahow-8/20/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News